Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

Journal of Clinical Oncology

Volumn 26, Issue 4, 2008, Pages 556-562

  Partridge, Ann H ^a   LaFountain, Andrea ^a   Mayer, Erica ^a   Taylor, Brooke S ^a   Winer, Eric ^a   Asnis Alibozek, Aviva ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; NITRILE; TRIAZOLE DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; EARLY STAGE BREAST CANCER; FEMALE; HEALTH PROGRAM; HUMAN; INTERVENTION STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK; BREAST TUMOR; CANCER STAGING; MIDDLE AGED; PATHOLOGY; PRESCRIPTION; STATISTICS; VALIDATION STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOPLASM STAGING; NITRILES; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; TRIAZOLES;

EID: 39149111976     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.5451     Document Type: Article

References (37)

1. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 353:487-497, 2005
2. Sabate E: Adherence to Long-Term Therapies: Evidence for Action. Basel, Switzerland, World Health Organization, 2003
3. Partridge AH, Avorn J, Wang PS, et al: Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652-661, 2002
4. Demissie S, Silliman RA, Lash TL: Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19:322-328, 2001
5. Partridge AH, Wang PS, Winer EP, et al: Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602-606, 2003
6. Fink AK, Gurwitz J, Rakowski W, et al: Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22:3309-3315, 2004
7. Lash TL, Fox MP, Westrup JL, et al: Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 99:215-220, 2006
8. Barron TI, Connolly R, Bennett K, et al: Early discontinuation of tamoxifen: A Lesson for oncologists. Cancer 109:832-839, 2007
9. Baum M, Budzar AU, Cuzick J, et al: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet 359:2131-2139, 2002
10. Goss PE, Ingle JN, Martino S, et al: A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793-1802, 2003
11. Coombes RC, Hall E, Gibson LJ, et al: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092, 2004
12. Coates AS, Keshaviah A, Thurlimann B, et al: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: Update of Study BIG 1-98. J Clin Oncol 25:486-492, 2007
13. Steiner JF, Koepsell TD, Fihn SD, et al: A general method of compliance assessment using centralized pharmacy records: Description and validation. Med Care 26:814-823, 1988
14. Gurwitz JH, Glynn RJ, Monane M, et al: Treatment for glaucoma: Adherence by the elderly. Am J Public Health 83:711-716, 1993
15. Monane M, Bohn R, Gurwitz JH, et al: Non-compliance with congestive heart failure therapy in the elderly. Arch Intern Med 154:433-437, 1994
16. Avorn J, Monette J, Lacour A, et al: Persistence of use of lipid-lowering medications: A cross-national study. JAMA 279:1458-1462, 1998
17. Monane M, Bohn RL, Gurwitz JH, et al: Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age, gender, and race. Am J Public Health 86:1805-1808, 1996
18. Fisher B, Costantino J, Redmond C, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors. N Engl J Med 320:479-484, 1989
19. Love RR: Prospects for antiestrogen chemoprevention of breast cancer. J Natl Cancer Inst 82:18-21, 1990
20. Waterhouse DM, Calzone KA, Mele C, Brenner DE: Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 11:1189-1197, 1993
21. United States Department of Health and Human Services Office for Human Research Protections (OHRP). http://www.dhhs.gov/ohrp/. Accessed 2007
22. Tebbi CK: Treatment compliance in childhood and adolescence. Cancer 71:3441-3449, 1993
23. Sackett DL, Haynes RB: Compliance With Therapeutic Regimens. Baltimore, MD, The Johns Hopkins University Press, 1976
24. Blackwell B: The drug defaulter. Clin Pharmacol Ther 13:841-848, 1972
25. Lebovits AH, Strain JJ, Schleifer SJ, et al: Patient noncompliance with self-administered chemotherapy. Cancer 65:17-22, 1990
26. Greenberg RN: Overview of patient compliance with medication dosing: A literature review. Clin Ther 6:592-599, 1984
27. Bonadonna MD, Valagussa P: Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304:10-15, 1981
28. Urquhart J: Compliance and clinical trials. Lancet 337:1224-1225, 1991
29. Lasagna L, Hutt P: Heath care, research and regulatory impact of noncompliance, in Cramer JA, Spikler BE (eds): Patient Compliance in Medical Practice and Clinical Trials. New York, NY, Raven Press, 1991, pp 393-403
30. Atkins L, Fallowfield L: Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer 42:2271-2276, 2006
31. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 351:1451-1467, 1998
32. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: Swedish Breast Cancer Cooperative Group. J Natl Cancer Inst 88:1543-1549, 1996
33. Grunfeld EA, Hunter MS, Sikka P, Mittal S: Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 59:97-102, 2005
34. Dixon JM, Renshaw L, Young O, et al: Anastrozole and letrozole: An investigation and comparison of quality of life, tolerability and morbidity. Breast Cancer Res Treat 100:S24, 2006 (abstr 105)
35. Leventhal H, Nerenz D, Leventhal E, et al: The behavioral dynamics of clinical trials. Prev Med 20:132-146, 1991
36. Choo PW, Rand CS, Inui TS, et al: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37:846-857, 1999
37. American Cancer Society: Breast Cancer Facts and Figures 2005-2006. Atlanta, GA, American Cancer Society, 2006